Antimicrobial susceptibility of 15,644 pathogens from Canadian hospitals: results of the CANWARD 2007–2009 study
Tóm tắt
Từ khóa
Tài liệu tham khảo
Biedenbach, 2004, Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY antimicrobial surveillance program (1997–2002), Diagn. Microbiol. Infect. Dis., 50, 59, 10.1016/j.diagmicrobio.2004.05.003
Castanheira, 2010, Antimicrobial susceptibility patterns of KPC-producing or CTX-M-producing Enterobacteriaceae, Microb. Drug Resist., 16, 61, 10.1089/mdr.2009.0031
Christianson, 2007, Comparative genomics of Canadian epidemic lineages of methicillin-resistant Staphylococcus aureus, J. Clin. Microbiol., 45, 1904, 10.1128/JCM.02500-06
Clinical and Laboratory Standards Institute, 2009
Clinical and Laboratory Standards Institute, 2010
Deshpande, 2007, Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: A report from the SENTRY antimicrobial surveillance program, Diagn. Microbiol. Infect. Dis., 58, 163, 10.1016/j.diagmicrobio.2006.12.022
Eliopoulos, 2009, Microbiology of drugs for treating multiply drug-resistant Gram- positive bacteria, J. Infect., 59, S17, 10.1016/S0163-4453(09)60004-9
Farrell, 2009, Linezolid surveillance program results for 2008 (LEADER program for 2008), Diagn. Microbiol. Infect. Dis., 65, 392, 10.1016/j.diagmicrobio.2009.10.011
Farrell, 2010, Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infections, Antimicrob. Agents Chemother., 54, 2735, 10.1128/AAC.01774-09
Golding, 2008, A preliminary guideline for the assignment of methicillin-resistant Staphylococcus aureus to a Canadian pulsed-field electrophoresis epidemic type using spa typing, Can. J. Infect. Dis. Med. Microbiol., 19, 273, 10.1155/2008/754249
Hoban, 2011, Introduction to the CANWARD study, 2007–2009, Diagn Microbiol Infect Dis, 69, 289, 10.1016/j.diagmicrobio.2010.10.024
Jones, 2009, Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the SENTRY antimicrobial surveillance program (1997–2007), Diagn. Microbiol. Infect. Dis., 65, 331, 10.1016/j.diagmicrobio.2009.06.022
Jones, 2009, Zyvox annual appraisal of potency and spectrum program: linezolid surveillance program results for 2008, Diagn. Microbiol. Infect. Dis., 65, 404, 10.1016/j.diagmicrobio.2009.10.001
Lockhart, 2007, Antimicrobial resistance among Gram-negative bacilli as causes of infections in intensive care unit patients in the United States between 1993–2004, J. Clin. Microbiol., 45, 3352, 10.1128/JCM.01284-07
Mulvey, 2001, Development of a Canadian standardized protocol for subtyping methicillin-resistant Staphylococcus aureus using pulsed-field gel electrophoresis, J. Clin. Microbiol., 39, 3481, 10.1128/JCM.39.10.3481-3485.2001
Mulvey, 2005, Community-associated methicillin-resistant Staphylococcus aureus, Canada Emerg. Infect. Dis., 11, 844, 10.3201/eid1106.041146
Oliveira, 2002, Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus, Antimicrob. Agents Chemother., 46, 2155, 10.1128/AAC.46.7.2155-2161.2002
Putnam, 2010, Sustained antimicrobial activity of tigecycline against methicillin-resistant Staphylococcus aureus (MRSA) from United States medical centres from 2004 through 2008, J. Chemother., 22, 13, 10.1179/joc.2010.22.1.13
Rhomberg, 2009, Summary trends for the meropenem yearly susceptibility test information collection program: a 10 year experience in the United States (1999–2008), Diagn. Microbiol. Infect. Dis., 65, 414, 10.1016/j.diagmicrobio.2009.08.020
Rubinstein, 2007, Anti-infectives research and development problems challenges and solutions: The clinical practitioner perspective, Lancet Infect. Dis., 7, 69
Sader, 2009, Antimicrobial susceptibility Gram-positive bacteria isolated from US medical centres: Results of the daptomycin surveillance program (2007–2008), Diagn. Microbiol. Infect. Dis., 65, 158, 10.1016/j.diagmicrobio.2009.06.016
Sader, 2010, Antimicrobial activity of daptomycin tested against Staphylococcus aureus with vancomycin MIC of 2 microg/mL isolated in the United States and European hospitals (2006–2008), Diagn. Microbiol. Infect. Dis., 66, 329, 10.1016/j.diagmicrobio.2009.09.017
Simor, 2010, Antimicrobial susceptibilities of healthcare-associated and community-associated strains of methicillin-resistant Staphylococcus aureus from hospitalized patients in Canada 1995–2008, Antimicrobial. Agents Chemother., 54, 2265, 10.1128/AAC.01717-09
Walkty, 2009, In vitro activity of colistin (polymyxin E) against 3480 isolates of Gram-negative bacilli obtained from patients in Canadian hospitals in the CANWARD study 2007–2008, Antimicrob. Agents Chemother., 53, 4924, 10.1128/AAC.00786-09
Wang, 2010, In vitro activity of tigecycline and comparators on Acinetobacter spp. isolates collected from patients with bacteremia and MIC change during the tigecycline evaluation and surveillance trial, 2004 to 2008, Diagn. Microbiol. Infect. Dis., 68, 73, 10.1016/j.diagmicrobio.2010.04.002
Wilson, 2010, Trends among pathogens reported as causing bacteraemia in England, 2004 to 2008, Clin. Microbiol. Infect.
Zhanel, 2008, Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006, Diagn. Microb. Infect. Dis., 62, 67, 10.1016/j.diagmicrobio.2008.04.012
Zhanel, 2008, Antimicrobial resistant pathogens in intensive care units across Canada: results of the Canadian National Intensive Unit (CAN-ICU) study, 2005/6, Antimicrob. Agents Chemother., 52, 1430, 10.1128/AAC.01538-07